CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Millions, unless otherwise specified	3 Months Ended
	Sep. 28, 2013	Sep. 29, 2012
OPERATING ACTIVITIES:
Net income (loss)	$ 0.3	$ (11.6)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation expense	17.8	17.0
Amortization of acquired technologies and other intangibles	14.1	20.8
Stock-based compensation	15.7	12.7
Amortization of debt issuance costs and accretion of debt discount	3.3	4.5
Other	2.0	2.4
Changes in operating assets and liabilities, net of impact of acquisition of business:
Accounts receivable	(18.6)	34.8
Inventories	2.4	0.8
Other current and non-current assets	(4.4)	(12.7)
Accounts payable	29.5	(0.7)
Deferred revenue, current and non-current	1.7	(7.3)
Deferred taxes, net	(4.9)	(1.9)
Accrued payroll and related expenses	(22.8)	(14.0)
Accrued expenses and other current and non-current liabilities	(6.6)	(1.7)
Net cash provided by operating activities	29.5	43.1
INVESTING ACTIVITIES:
Purchases of available-for-sale investments	(470.5)	(147.8)
Maturities of available-for-sale investments	46.8	85.3
Sales of available-for-sale investments	25.7	17.3
Changes in restricted cash	(0.5)	(0.4)
Acquisition of business, net of cash acquired	(0.1)	(9.1)
Acquisition of property and equipment	(12.4)	(17.8)
Proceeds from the sale of assets	0.1
Net cash used in investing activities	(410.9)	(72.5)
FINANCING ACTIVITIES:
Proceeds from issuance of senior convertible debt	650.0
Payment of debt issuance costs	(13.5)
Repurchase and retirement of common stock	(100.0)
Redemption of senior convertible debt		(47.8)
Payment of financing obligations	(0.3)	(0.2)
Proceeds from exercise of employee stock options and employee stock purchase plan	11.6	6.9
Net cash provided (used in) by financing activities	547.8	(41.1)
Effect of exchange rate changes on cash and cash equivalents	1.9	2.0
Increase (decrease) in cash and cash equivalents	168.3	(68.5)
Cash and cash equivalents at beginning of period	281.0	401.1
Cash and cash equivalents at end of period	$ 449.3	$ 332.6